According to a government survey conducted in Japan in 2023, 52.5 percent of respondents answered that they would receive cancer immunotherapy if their doctor recommended it. 31.9 percent of respondents thought it was difficult to judge which information on cancer immunotherapy is accurate.
Opinion on cancer immunotherapy in Japan as of August 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Cabinet Office Japan. (October 20, 2023). Opinion on cancer immunotherapy in Japan as of August 2023 [Graph]. In Statista. Retrieved December 25, 2024, from https://www.statista.com/statistics/1434237/japan-opinion-on-cancer-immunotherapy/
Cabinet Office Japan. "Opinion on cancer immunotherapy in Japan as of August 2023." Chart. October 20, 2023. Statista. Accessed December 25, 2024. https://www.statista.com/statistics/1434237/japan-opinion-on-cancer-immunotherapy/
Cabinet Office Japan. (2023). Opinion on cancer immunotherapy in Japan as of August 2023. Statista. Statista Inc.. Accessed: December 25, 2024. https://www.statista.com/statistics/1434237/japan-opinion-on-cancer-immunotherapy/
Cabinet Office Japan. "Opinion on Cancer Immunotherapy in Japan as of August 2023." Statista, Statista Inc., 20 Oct 2023, https://www.statista.com/statistics/1434237/japan-opinion-on-cancer-immunotherapy/
Cabinet Office Japan, Opinion on cancer immunotherapy in Japan as of August 2023 Statista, https://www.statista.com/statistics/1434237/japan-opinion-on-cancer-immunotherapy/ (last visited December 25, 2024)
Opinion on cancer immunotherapy in Japan as of August 2023 [Graph], Cabinet Office Japan, October 20, 2023. [Online]. Available: https://www.statista.com/statistics/1434237/japan-opinion-on-cancer-immunotherapy/
